SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Canadian Political Free-for-All -- Ignore unavailable to you. Want to Upgrade?


To: teevee who wrote (37293)12/3/2025 10:47:44 PM
From: gg cox  Read Replies (1) | Respond to of 37549
 
There’s 11 variations doctor tee wee which variation have I encountered one, or all eleven?

2 Nobel prizes handed out for discovery in 2005… 18 years of STUDY by those know ,,before Nobels awarded .

Vaccines
When pseudouridine is used in place of uridine in synthetic mRNA, the modified mRNA molecule arouses less response from Toll-like receptors, a part of the human immune system that would otherwise identify the mRNA as unwelcome. This makes pseudouridine useful in mRNA vaccines, including the mRNA COVID-19 vaccines. This property of pseudouridine was discovered by Katalin Karikó and Drew Weissman in 2005, for which they shared the 2023 Nobel Prize in Physiology or Medicine. [21] [22]

N1-Methylpseudouridine provides even less innate immune response than ?, as well as improving translation capacity. [23] Both Pfizer-BioNTech and ModernamRNA vaccines therefore use N1-Methylpseudouridine rather than ?. [23]

Please explain tee wee.

“ Pseudouridine modifications are also implicated in human diseases such as mitochondrial myopathy and sideroblastic anemia (MLASA) and Dyskeratosis congenita. [10] Dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome are two rare inherited syndromes caused by mutations in DKC1, the gene encoding for the pseudouridine synthase dyskerin. Pseudouridines have been recognized as regulators of viral latencyprocesses in human immunodeficiency virus (HIV) infections. [20] Pseudouridylation has also been associated with the pathogenesis of maternally inherited diabetes and deafness (MIDD). In particular, a point mutation in a mitochondrial tRNA seems to prevent the pseudouridylation of one nucleotide, thus altering the tRNA tertiary structure. This may lead to higher tRNA instability, causing deficiencies in mitochondrial translation and respiration. [20]. “